Today’s Solutions: August 10, 2022

Before, we published the results of a new study that found psilocybin therapy to be four times more effective than antidepressants for treating major depression disorders (MDD). Staying within the theme of psilocybin research, we have news about a first-of-its-kind exploratory study that has promising results regarding the effect of magic mushrooms on migraines.

As described in NewAtlas, the study comes from the Yale School of Medicine and offers the first double-blind, placebo-controlled, cross-over study on the effects of a moderate psilocybin dose on migraine frequency and severity. What the researchers found was that a single dose of psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. 

The study recruited ten migraine sufferers, all of whom completed two sessions with researchers, one with a placebo and one with a moderate psilocybin dose. Headache diaries were used to track headache frequency and severity in the two weeks leading up to, and following each experimental session. From this, the researchers could conclude that a single dose of psilocybin not only reduced migraine frequency in half but also reduced the actual pain intensity and functional impairment during migraine attacks by approximately 30 percent.

Although the research sample is small, the results are encouraging and will surely lead to further research. One particularly interesting finding from this small study was the lack of any correlation between the subjective strength of the psychedelic experience and the therapeutic effect. Prior studies had shown that the magnitude of a psychedelic experience seems to be fundamentally entwined with its therapeutic efficacy, but this study did not detect this association. This suggests that it may be possible to separate the drug’s psychotropic effects from its therapeutic effects.

We must reiterate that this was a small study and that we can’t draw too many conclusions from it. That said, it’s incredibly exciting to see new research on the healing benefits of psilocybin being published, especially considering how research on psychedelic drugs was criminalized and labeled taboo in the decades before.

Solutions News Source Print this article
More of Today's Solutions

Burger King Austria makes plant-based their “new normal”

Burger King Austria’s new campaign is boldly challenging the public’s expectation of what “normal” ought to be. In a climate-conscious world, making plant-based the default standard for burgers is quite a statement. The brand's experiment ... Read More

Irish beekeeper constructs colorful LEGO hive in his backyard

From cleaning out the basement to taking up bread making, people around the world have taken up new hobbies to fill their quarantined time. One creative bee-lover in Ireland decided to use the time to ... Read More

Instagram adds a field for your gender identity pronoun preferences

Instagram announced an exciting change to their platform in 2021—the introduction of a new field where users can specify their preferred gender identity pronouns on their profile. You can add up to four gender identity ... Read More

Your future rooftop could be made out of easy-to-install solar shingles

The roofs of the future may be made entirely out of solar panels. At least that’s the goal of GAF Energy, which has recently launched a new solar roof that it believes can revolutionize the ... Read More